Impact of disease duration on systemic clinical profile in Sjogren's syndrome.

Furthermore, central nervous system (CNS) involvement, including diseases such as cerebrovascular disease and cognitive dysfunction, shows an increasing trend, starting at 0.26% in the T0 group and reaching 2.48% in the T4 group (Fig. 1 G and Table 3 ; p < 0.0001).

also in 63,971 other papers